More than £7m of charity funding has been allocated to Scotland to bring new and better cancer treatments to patients more quickly.
Cancer Research Scotland will award £7,360,135 in funding to train early-career clinician scientists – doctors who also carry out medical research - as part of its Clinical Academic Training Programme.
Clinician scientists play an essential role in translating cancer research, helping to bridge the gap between scientific research carried out in laboratories and clinical research involving patients.
Working across both research settings, their contributions to new knowledge and its translation to clinical practice are critical for cancer research.
Becoming a clinician scientist usually involves doctors taking time out of their medical training to undertake a PhD, before returning to train in their chosen specialisation, but many clinicians don’t come back to research after qualifying as consultants.
This may be due to existing pressure on the healthcare system and lack of available funding, Cancer Research UK said.
Nearly three quarters (74%) of clinical research staff surveyed by Cancer Research UK in 2023 said that it has become harder to deliver research in a timely manner in the last 18 months, with 78% of respondents describing wider pressures on the health service as a substantial or extreme barrier.
To tackle this issue, Cancer Research UK’s Clinical Academic Training Programme provides flexible training options alongside mentorship and networking opportunities to better support clinicians who want to get involved and stay in cancer research.
The funding has been divided between University of Glasgow, University of Edinburgh, Cancer Research UK Scotland Institute, NHS Lothian, NHS Greater Glasgow and Clyde, and the Beatson West of Scotland Cancer Centre .
Read More:
-
Safety review ordered into Glasgow superhospital after A&E doctors raise alarm
-
More time on social media ‘linked to smoking and vape use among teenagers’
-
Liam McArthur offers meeting with Nicola Sturgeon to 'allay fears' on assisted dying
Professor Charlie Gourley, Clinical Director of the Cancer Research UK Scotland Centre and co lead of the programme in Scotland alongside Professor Richard Wilson of the University of Glasgow, said: “We are delighted to gain further Cancer Research UK funding and to work with colleagues across Scotland and the north of the UK to offer doctors new and flexible training opportunities so that they can become the clinical cancer researcher leaders of the future.
“It is vital for our scientists to be able to work together in the lab with clinicians at all levels and specialities to find new and better treatments for cancer. This will undoubtedly lead to benefits for cancer patients in the longer term.
“My personal experience of balancing treating cancer patients while actively researching the disease has taught me that our support and mentorship of young cancer clinician scientists is crucial to ensure they achieve their goals and improve the outcome for the patients of the future”.
Michelle Mitchell, Cancer Research UK’s Chief Executive, said: “Clinician scientists have a very important role to play by bringing their knowledge and experience of treating people with cancer to scientific research.
“We need all our doctors and scientists to be able to reach their full potential, no matter their background. That’s why we are continuing to provide flexible training options for early-career clinician scientists.
“After the success of the first five years of this programme, we want to encourage even more clinicians to get involved in cancer research to help us get closer to a world where everybody lives longer, better lives free from the fear of cancer.”
Why are you making commenting on The Herald only available to subscribers?
It should have been a safe space for informed debate, somewhere for readers to discuss issues around the biggest stories of the day, but all too often the below the line comments on most websites have become bogged down by off-topic discussions and abuse.
heraldscotland.com is tackling this problem by allowing only subscribers to comment.
We are doing this to improve the experience for our loyal readers and we believe it will reduce the ability of trolls and troublemakers, who occasionally find their way onto our site, to abuse our journalists and readers. We also hope it will help the comments section fulfil its promise as a part of Scotland's conversation with itself.
We are lucky at The Herald. We are read by an informed, educated readership who can add their knowledge and insights to our stories.
That is invaluable.
We are making the subscriber-only change to support our valued readers, who tell us they don't want the site cluttered up with irrelevant comments, untruths and abuse.
In the past, the journalist’s job was to collect and distribute information to the audience. Technology means that readers can shape a discussion. We look forward to hearing from you on heraldscotland.com
Comments & Moderation
Readers’ comments: You are personally liable for the content of any comments you upload to this website, so please act responsibly. We do not pre-moderate or monitor readers’ comments appearing on our websites, but we do post-moderate in response to complaints we receive or otherwise when a potential problem comes to our attention. You can make a complaint by using the ‘report this post’ link . We may then apply our discretion under the user terms to amend or delete comments.
Post moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours.
Read the rules here